TE 441.THomo sapiens (Human)Cancer cell line

Also known as: TE441T, TE-441-T

🤖 AI SummaryBased on 4 publications

Quick Overview

Human cancer cell line with unknown tissue and disease origin.

Detailed Summary

TE 441.T is a human cancer cell line with unknown tissue and disease origins. It is part of the Cancer Cell Line Encyclopedia (CCLE) and has been profiled for genomic and pharmacological data. The cell line is used in research to understand drug sensitivity and predictive modeling of anticancer treatments. Its genomic characteristics include mutations and gene expression profiles that contribute to its utility in studying cancer biology and therapeutic responses.

Research Applications

Drug sensitivity profilingPredictive modeling of anticancer treatmentsGenomic and pharmacological data analysis

Key Characteristics

Genomic mutationsGene expression profilesPharmacological response data
Generated on 6/17/2025

Basic Information

Database IDCVCL_1754
SpeciesHomo sapiens (Human)
Tissue SourceConnective tissue[UBERON:UBERON_0002384]

Donor Information

Age14
Age CategoryPediatric
SexFemale
Raceblack_or_african_american
Subtype FeaturesCIC_DUX4

Disease Information

DiseaseRhabdomyosarcoma
LineageSoft Tissue
SubtypeCIC-DUX4 Sarcoma

DepMap Information

Source TypeATCC
Source IDACH-000772_source

Haplotype Information (STR Profile)

Short Tandem Repeat (STR) profile for cell line authentication.

Amelogenin
X
CSF1PO
12
D13S317
12
D16S539
11,12
D18S51
13,23
D19S433
12,14
D21S11
29,30
D2S1338
21,22
D3S1358
16,17
D5S818
10,12
D7S820
10
D8S1179
14,15
FGA
23,25
Penta D
2.2,8
Penta E
16
TH01
7,9
TPOX
7,8
vWA
15,16
Gene Expression Profile
Gene expression levels and statistical distribution
Loading cohorts...
Full DepMap dataset with combined data across cell lines

Loading gene expression data...

Publications

Pan-cancer proteomic map of 949 human cell lines.";

Robinson P.J., Zhong Q., Garnett M.J., Reddel R.R.

Cancer Cell 40:835-849.e8(2022).

Next-generation characterization of the Cancer Cell Line Encyclopedia.

Sellers W.R.

Nature 569:503-508(2019).

An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines.

Dutil J., Chen Z.-H., Monteiro A.N.A., Teer J.K., Eschrich S.A.

Cancer Res. 79:1263-1273(2019).

A landscape of pharmacogenomic interactions in cancer.";

Wessels L.F.A., Saez-Rodriguez J., McDermott U., Garnett M.J.

Cell 166:740-754(2016).

TCLP: an online cancer cell line catalogue integrating HLA type, predicted neo-epitopes, virus and gene expression.

Loewer M., Sahin U., Castle J.C.

Genome Med. 7:118.1-118.7(2015).

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.

Morrissey M.P., Sellers W.R., Schlegel R., Garraway L.A.

Nature 483:603-607(2012).

Signatures of mutation and selection in the cancer genome.";

Deloukas P., Yang F.-T., Campbell P.J., Futreal P.A., Stratton M.R.

Nature 463:893-898(2010).